beta-Thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants

Area of Science:

• Hematology
• Genetics
• Neonatal Medicine

Background:

• Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency is a common inherited disorder.
• Neonatal hyperbilirubinemia is a frequent complication in infants with G-6-PD deficiency.
• The potential protective role of the beta-thalassemia trait against this complication is unclear.

Purpose of the Study:

• To investigate whether the beta-thalassemia trait offers protection against neonatal hyperbilirubinemia in infants with G-6-PD deficiency.
• To compare the incidence of neonatal hyperbilirubinemia in G-6-PD deficient infants with and without the beta-thalassemia trait.

Main Methods:

• Hb A2 levels were determined in two groups of infants with G-6-PD deficiency.
• Group 1: 50 infants with G-6-PD deficiency and neonatal hyperbilirubinemia.
• Group 2: 100 infants with G-6-PD deficiency but no neonatal hyperbilirubinemia.

Main Results:

• Six subjects in Group 1 and 13 subjects in Group 2 were identified as carriers of the beta-thalassemia trait.
• Statistical analysis revealed no significant difference in the prevalence of the beta-thalassemia trait between the hyperbilirubinemic and non-hyperbilirubinemic groups.
• The beta-thalassemia trait was present in 12% of the hyperbilirubinemic G-6-PD deficient infants and 13% of the non-hyperbilirubinemic G-6-PD deficient infants.

Conclusions:

• The beta-thalassemia trait does not appear to provide a protective effect against neonatal hyperbilirubinemia in infants with G-6-PD deficiency.
• Further research may be needed to explore other genetic or environmental factors influencing hyperbilirubinemia in this population.